HIGHLIGHTS
- who: Han-Mo Yang from the Siena University Hospital, Italy have published the Article: Long-term use of renin-angiotensin system inhibitors after acute myocardial infarction is not associated with survival benefits: Analysis of data from the Korean acute myocardial infarction registry-national institutes of health registry, in the Journal: (JOURNAL) of 31/08/2022
- what: This study provides valuable information regarding tailored medication strategy after acute MI. To answer these questions, the authors aimed to investigate the clinical outcomes of longterm RASi use in a large, prospective, multicenter study of patients with acute MI . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.